Sriram Yennu
M.D. Anderson Cancer Center · MD Anderson
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sriram Yennu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:23 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT06085716 · Combination Therapy for Cancer Related Fatigue in Patients With Metastatic CancersM.D. Anderson Cancer Center · recruiting · Metastatic Cancers, Fatigue · principal investigator
- N/ANCT05634551 · Perceptions on Expected Outcomes of Immunotherapy in Advanced Cancer Patients With Poor Performance StatusM.D. Anderson Cancer Center · completed · Non-small Cell Lung Cancer · principal investigator
- Ph2/Ph3NCT05474846 · Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced CancerM.D. Anderson Cancer Center · active not recruiting · Sleep, Fatigue, Anxiety · principal investigator
- Ph2NCT05077072 · Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer PatientsM.D. Anderson Cancer Center · active not recruiting · Head and Neck Carcinoma · principal investigator
- N/ANCT05044312 · Sleep Disturbances in Surgical Patients With GI Cancers: A Quantitative and Qualitative AnalysisM.D. Anderson Cancer Center · withdrawn · GI Cancers, Gastrointestinal Cancer · principal investigator
- Ph2NCT04984551 · Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and EthiopiaM.D. Anderson Cancer Center · recruiting · Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm · principal investigator
- Ph2/Ph3NCT03927885 · Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced CancerM.D. Anderson Cancer Center · active not recruiting · Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm · principal investigator
- Ph2/Ph3NCT03772834 · Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate CancerM.D. Anderson Cancer Center · active not recruiting · Prostate Carcinoma · principal investigator
- Ph2NCT03747757 · Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related FatigueM.D. Anderson Cancer Center · active not recruiting · Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Cancer Fatigue · principal investigator
- Ph2/Ph3NCT03637816 · Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung CancerM.D. Anderson Cancer Center · active not recruiting · Anorexia, Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 · principal investigator
- Ph2NCT03583255 · Physical Activity With or Without Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Locally Advanced, Metastatic, or Recurrent CancerM.D. Anderson Cancer Center · active not recruiting · Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid System Neoplasm, Locally Advanced Malignant Solid Neoplasm · principal investigator
- Ph3NCT03525873 · A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 ImmunotherapyM.D. Anderson Cancer Center · active not recruiting · Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Recurrent Malignant Neoplasm · principal investigator
- Ph2NCT03035409 · Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid TumorsM.D. Anderson Cancer Center · active not recruiting · Advanced Malignant Solid Neoplasm, C-Reactive Protein Measurement, Cancer Fatigue · principal investigator
- Ph2NCT02940223 · Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced CancerM.D. Anderson Cancer Center · terminated · Advanced Malignant Neoplasm, Fatigue · principal investigator
- Ph2/Ph3NCT02491632 · Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced CancerM.D. Anderson Cancer Center · active not recruiting · Advanced Malignant Neoplasm, Fatigue, Metastatic Malignant Neoplasm · principal investigator
- Ph2NCT01628029 · Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With CancerM.D. Anderson Cancer Center · active not recruiting · Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Sleep Disorder · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- A Combination Therapy to Treat Cancer-Related FatigueR01CA231521 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2019 to 2023 · $498,007 awarded in 2023Same name and institution; not confirmed by an ID
- Opioid-Sparing Interdisciplinary Interventions Addressing Pain in Head and Neck Cancer PatientsR21CA252446 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2021 to 2022 · $185,552 awarded in 2022Same name and institution; not confirmed by an ID
- A Combination Therapy for Cancer-Related Fatigue in Advanced Cancer PatientsR21NR016737 · NINR · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2018 to 2019 · $165,903 awarded in 2019Grant number is on one of their registry trials
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Experimental Medicine ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FUNDA MERIC-BERNSTAM · fiscal years 2013 to 2026Named on NCT03747757
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.